Skip to main content

Table 5 Medications prescribed for outpatient use in tertiary and secondary care hospitals

From: Improved treatment and prognosis after acute myocardial infarction in Estonia: cross-sectional study from a high risk country

 

Year 2001

Year 2007

Year 2011

P value for trend

%

%

%

Tertiary care hospitals

n = 181

n = 290

n = 261

 

 Aspirin

85.1

93.1

95.4

<0.001

 P2Y12-receptor inhibitors

18.2

64.8

72.8

<0.001

 Betablockers

71.3

80.0

85.4

<0.001

 ACEi/ARB

66.3

77.2

84.7

<0.001

 Statins

31.5

73.4

80.8

<0.001

 Nitrates

61.9

22.1

15.8

<0.001

Secondary care hospitals

n = 163

n = 224

n = 184

 

 Aspirin

79.8

82.6

91.3

0.004

 P2Y12-receptor inhibitors

0.6

10.7

32.8

<0.001

 Betablockers

68.7

80.9

82.8

0.001

 ACEi/ARB

37.4

68.9

68.3

<0.001

 Statins

14.7

37.3

65.6

<0.001

 Nitrates

85.3

58.2

41.4

<0.001

  1. ACEi angiotensin-converting enzyme inhibitors, ARB angiotensin II receptor blockers, P2Y12-receptor inhibitors – ticlopidine/clopidogrel/ticagrelol